Victor Faubeau

Founder & CEO @ 404 SOLUTIONS

📍 France🔄 Updated September 2026💼 12 investments📅 2 years investing🗓 Last invested Sep 2025
Operator-angel🌍 FranceInvested this year
12
Total investments
0
Early stage
7
Mid stage
3
Late stage
2y
Years active

Portfolio

11 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Sep 2025
Specialising in tissue engineering and 3D printing, we develop innovative implants for soft tissue regeneration using biomaterials. With the aim of providing patients with a better quality of care, Lattice Medical has developed two devices: MATTISSE, a 3D-printed resorbable breast implant, and RODIN, a matrix for regenerating the hypodermis.
Private Investor
Jun 2025
One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences.
Private Investor
May 2025
U-Space designs and builds constellation-ready small satellites. Our company offers both a 16U and a microsatellite (the FreeForm) to address the civil, commercial and defense markets. We help our customers from their mission design to the operation of their constellation in our own control center. Through our offers and our dedication, we aim to facilitate access to space for those wishing to improve the human condition and contribute to the further exploration of the unknown.
Private Investor
May 2025
Via App fördern und verbessern wir das Allgemeinwissen unserer Nutzer. Spielerisch und einfach integrieren wir Allgemeinbildung in den Alltag der Menschen, die ihren Horizont erweitern und ihr Know-How trainieren wollen.
Private Investor
Mar 2025
MINT Bikes est une jeune entreprise givrée basée à Aix-en-Provence ayant pour ambition de mettre une béquille au tout jetable. On cherche les meilleurs talents pour accomplir cette mission. Lancée début 2021, MINT Bikes veut révolutionner le marché en démocratisant le vélo reconditionné comme une véritable alternative au neuf et à l’occasion entre particuliers. L’ambition est de jouer un rôle de premier plan sur ce marché de 15 Mds € en forte croissance. MINT Bikes a été cofondée par Jules, un étudiant de 21 ans, et Rod, un ancien tennisman professionnel. Seb et David, fondateurs de Voyage Privé et de Kiss Studio, ont ensuite rejoint l’aventure. Notre métier est simple : MINT Bikes reconditionne des vélos haut-de-gamme à la perfection, ici, en France. C’est la garantie d’un vélo fiable, économique et écologique dans un état impeccable. Aujourd’hui, MINT Bikes c’est 35 personnes, toutes plus engagées les unes que les autres pour mettre à l’honneur le vélo, démocratiser la seconde main. #Onrecrute Pourquoi recrutons-nous ? Pour accompagner les fortes ambitions et croissances de l’activité, et poursuivre notre développement grâce à notre récente levée de fond de 3M€.
Private Investor
Mar 2025
Wheere is a French deeptech company revolutionizing indoor geolocation. Our technology is the only one capable of covering a site of one square kilometer with just four transmitters. By leveraging unmodulated low-frequency waves and a unique algorithm, our solution penetrates even the densest obstacles, such as concrete walls, and offers a sub-meter accuracy. Founded in 2021 by Pierre-Arnaud Coquelin and Antoine Carrabin, Wheere successfully closed an €11 million seed round in July 2023. At Wheere, our mission is to make indoor geolocation as accessible as GPS—ubiquitous, affordable, and integrated into all B2C and B2B devices. To achieve this, we have two key milestones ahead: - By 2027: Reduce the size, energy consumption, and production costs of our receivers. - By 2030: Achieve global availability of our technology through the spatial deployment of our #LEOPNT transmitters.
Private Investor
Mar 2025
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology. At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women. Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine. Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability. Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future. 🌐 www.ziwig.com
Private Investor
Mar 2025
Single-use packaging were born to meet hygienic needs. However, access to cleanliness through disposable plastic is not inevitable! Thanks to a fast-cleaning gesture, auum transforms "single use" by "single move" in order to reuse endlessly. Auum innovates within the cleaning field through its SmartCleaning concept: a new, fast, convenient & sustainable cleaning technology. End Single Use Now!
Private Investor
Mar 2025
We turn your calls into clean, structured notes , so you don’t have to. 🧩 Built for recruiters, teams & leaders ✅ Save hours every week ✅ Stay focused in every meeting ✅ Get reports, insights & follow-ups automatically 💬 Works with Zoom, Meet, Teams, phone, or in person 🌍 Available in 80+ languages. Built in France, trusted by 1500+ teams ✨ Welcome to a more human way of work
Private Investor
2025
💶 Investissez aux côtés d’Anthony Bourbon 📈 Dans les startups de demain 💥 À partir de 1 000€ par projet. Rejoignez le club ! 👇 Des entrepreneurs à succès experts de leur verticales investissent également à vos côtés, aux mêmes conditions et au même moment. Thomas Rebaud (Meero, Licorne), Thomas Battistini (Jour, vendu 100M€), Rand Hindi (Zama), Louis Marty (Merci Handy...). Ils accompagnent en plus les fondateurs en les soutenant tout au long de laventure en ayant une place au board. Vous devenez actionnaire en quelques clics. Léquipe Blast Club soccupe de tout et lintégralité du process est digital, 100% en ligne. Anthony Bourbon investit dans TOUS les deals présentés, mais VOUS décidez ceux où vous souhaitez participer. Blast vous permet également de vous former et de rejoindre le club le plus puissant de France. Plus de 10 000 membres dans toute la France. En plus de profiter de ce réseau (annuaire, discord etc), participez à tous les événements physiques (afterwork, conférences...), les pitch live de toutes les startups, les "rencontres Blast" mensuelles avec des invités prestigieux et échangez quotidiennement sur notre forum déchange privé avec Anthony, les experts et les milliers de membres. Vous pourrez bien entendu suivre les performances de tous vos investissements et recevrez chaque trimestre un reporting précis de vos startups. Les membres peuvent également échanger avec les fondateurs sur le canal discord privé réservés aux actionnaires de chaque dossier. Rappel : Investir comporte des risques. Ninvestissez que largent donc vous navez pas besoin à court terme.
Private Investor
Nov 2024
In a world where automobiles are shifting from ownership to usage, the focus of value has now shifted more towards the experience than mere possession. Consumers seek flexible and simplified access to automobiles. Discover a new way to experience automobiles: subscription. Enjoy freedom and flexibility, and access the best that the automotive world has to offer.
Experience · 13 entries
All (13)
Investments (12)
Founder (1)
2025
Private Investor
Sep 2025
Specialising in tissue engineering and 3D printing, we develop innovative implants for soft tissue regeneration using biomaterials. With the aim of providing patients with a better quality of care, Lattice Medical has developed two devices: MATTISSE, a 3D-printed resorbable breast implant, and RODIN, a matrix for regenerating the hypodermis.
Founder & CEO
Jul 2025
404 SOLUTIONS accompagne les entreprises dans la gestion, l’optimisation et la sécurisation de leur système d’information. Nous intervenons comme DSI externalisé pour structurer l’IT, piloter les projets numériques, choisir les bons outils et maîtriser les coûts. Notre expertise couvre la stratégie IT, la gouvernance, le pilotage de prestataires, la cybersécurité et l’optimisation des environnements Microsoft. 404 SOLUTIONS aide les dirigeants à reprendre le contrôle de leur IT et à en faire un levier de performance durable.
Private Investor
Jun 2025
One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences.
Private Investor
May 2025
U-Space designs and builds constellation-ready small satellites. Our company offers both a 16U and a microsatellite (the FreeForm) to address the civil, commercial and defense markets. We help our customers from their mission design to the operation of their constellation in our own control center. Through our offers and our dedication, we aim to facilitate access to space for those wishing to improve the human condition and contribute to the further exploration of the unknown.
Private Investor
May 2025
Via App fördern und verbessern wir das Allgemeinwissen unserer Nutzer. Spielerisch und einfach integrieren wir Allgemeinbildung in den Alltag der Menschen, die ihren Horizont erweitern und ihr Know-How trainieren wollen.
Show all 13 entries ↓
Investment activity
2024–2025 · 12 investments
20241202511
Recent (last 2 years)Earlier